Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05292183 · ClinicalTrials.gov registry record · NA
Modulation of Emotion Perception in Humans Via Amygdala Stimulation
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05292183 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 16 participants.
The verdict
NCT05292183, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study will enroll patients with epilepsy who are being evaluated for epilepsy surgery and have intracranial EEG electrodes. In this study, the aim is to record brain signals from areas important in social and emotional processing and to understand how electrical brain stimulation - called neuromodulation - affects such processing. Patients enrolled in this study will be asked to view images depicting a variety of emotionally positive, negative, or neutral themes. As the patient views these images, a small amount of imperceptible and painless electric current will be used to map function of certain parts of a human brain. The overarching goal of the study is to determine if neuromodulation can be used in certain areas of the brain to treat cognitive disorders such as memory loss and post-traumatic stress disorder.
Interventions
- OTHER Electrical Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2024-02-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05292183
The ClinicalTrials.gov registry entry for NCT05292183 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electrical Stimulation is the first listed.
NCT05292183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05292183 about?
NCT05292183 is a clinical study titled "Modulation of Emotion Perception in Humans Via Amygdala Stimulation". This study will enroll patients with epilepsy who are being evaluated for epilepsy surgery and have intracranial EEG electrodes. In this study, the aim is to record brain signals from areas important in social and emotional processing and to understand how electrical brain stimulation - called neuro...
What is the current status of trial NCT05292183?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2022-03-31. Estimated completion is 2024-02-16.
What interventions are being tested in trial NCT05292183?
The interventions under investigation include: Electrical Stimulation (OTHER).
Who is sponsoring clinical trial NCT05292183?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.